VIXEN BIOSYSTEMS: what changed
What changed
VIXEN BIOSYSTEMS
NACE 72.101, Research and development on biotechnology
filed annual accounts (NBB)
Net result for the year
-€96,013
2024 · -€31,061-€64,952
Equity
€154,851
2024 · €20,460+€134,391
Cash
€506,230
2024 · €37,695+€468,535
Balance sheet total
€1.2m
2024 · €37,695+€1.2m
Largest movements
Assets
- Cash +€468,535
up €468,535 (+1,243%), from €37,695 to €506,230
mainly Debts after one year (+€800,502) and Contributions, distributions and other (+€230,404)
- Tangible fixed assets +€259,346
up €259,346, from €0 to €259,346
- Deferred charges and accrued income +€235,678
up €235,678, from €0 to €235,678
- Intangible fixed assets +€84,211
new in 2025: €84,211
- Receivables within one year +€75,677
new in 2025: €75,677
of which Other amounts receivable: +€45,636
Equity and liabilities
- Debts after one year +€800,502
new in 2025: €800,502
- Revaluation surpluses +€198,661
new in 2025: €198,661
- Accrued charges and deferred income +€151,725
new in 2025: €151,725
- Profit (loss) carried forward -€96,013
down €96,013, from €0 to -€96,013
- Trade debts +€55,562
up €55,562 (+432,390%), from €13 to €55,575
Income statement
- Staff costs +€192,656
new in 2025: €192,656
- Gross operating margin +€175,210
up €175,210, from -€24,727 to €150,482
- Depreciation +€43,623
up €43,623, from €0 to €43,623
- Financial charges +€4,643
up €4,643 (+121%), from €3,840 to €8,483
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€31,061
Gross operating margin
+€175,210
Staff costs
-€192,656
Depreciation
-€43,623
Other operating charges
-€186
Other operating items
+€2,060
Financial income
-€1,113
Financial charges
-€4,643
Result 2025
-€96,013
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€148,027
Investment
-€415,722
Financing
+€1.0m
Cash 2024
€37,695
From operations (derived)
-€148,027
Net result for the year
-€96,013
Depreciation
+€43,623
Receivables within one year
-€75,677
Deferred charges and accrued income
-€235,678
Trade debts
+€55,562
Tax, wage and social debts
+€24,516
Other debts
-€16,085
Accrued charges and deferred income
+€151,725
Investment (derived)
-€415,722
Investment in fixed assets (net)
-€415,722
Financing
+€1.0m
Debts after one year
+€800,502
Short-term financial debts
+€1,378
Contributions, distributions and other
+€230,404
Cash 2025
€506,230
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €37,695 | €1,189,684 | +€1.2m | +3,056% |
| Formation expenses | 20 | - | €18,668 | +€18,668 | |
| Fixed assets | 21/28 | €0 | €353,431 | +€353,431 | |
| Intangible fixed assets | 21 | - | €84,211 | +€84,211 | |
| Tangible fixed assets | 22/27 | €0 | €259,346 | +€259,346 | |
| Plant, machinery and equipment | 23 | - | €120,316 | +€120,316 | |
| Furniture and vehicles | 24 | - | €37,669 | +€37,669 | |
| Other tangible fixed assets | 26 | €0 | €101,361 | +€101,361 | |
| Financial fixed assets | 28 | - | €9,873 | +€9,873 | |
| Current assets | 29/58 | €37,695 | €817,585 | +€779,890 | +2,069% |
| Stocks and contracts in progress | 3 | €0 | - | = | |
| Stocks | 30/36 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | - | €75,677 | +€75,677 | |
| Trade receivables | 40 | - | €30,041 | +€30,041 | |
| Other amounts receivable | 41 | - | €45,636 | +€45,636 | |
| Cash at bank and in hand | 54/58 | €37,695 | €506,230 | +€468,535 | +1,243% |
| Deferred charges and accrued income | 490/1 | €0 | €235,678 | +€235,678 | |
| Total equity and liabilities | 10/49 | €37,695 | €1,189,684 | +€1.2m | +3,056% |
| Equity | 10/15 | €20,460 | €154,851 | +€134,391 | +657% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Revaluation surpluses | 12 | - | €198,661 | +€198,661 | |
| Reserves | 13 | €1,860 | €33,603 | +€31,743 | +1,707% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €0 | €31,743 | +€31,743 | |
| Profit (loss) carried forward | 14 | €0 | -€96,013 | -€96,013 | |
| Amounts payable | 17/49 | €17,235 | €1,034,833 | +€1.0m | +5,904% |
| Amounts payable after more than one year | 17 | - | €800,502 | +€800,502 | |
| Financial debts | 170/4 | - | €800,502 | +€800,502 | |
| Amounts payable within one year | 42/48 | €17,235 | €82,606 | +€65,371 | +379% |
| Financial debts | 43 | - | €1,378 | +€1,378 | |
| Credit institutions | 430/8 | - | €1,378 | +€1,378 | |
| Trade debts | 44 | €13 | €55,575 | +€55,562 | +432,390% |
| Suppliers | 440/4 | €13 | €55,575 | +€55,562 | +432,390% |
| Taxes, remuneration and social security | 45 | €1,002 | €25,518 | +€24,516 | +2,446% |
| Taxes | 450/3 | €1,002 | €743 | -€260 | -25.9% |
| Remuneration and social security | 454/9 | - | €24,776 | +€24,776 | |
| Other amounts payable | 47/48 | €16,220 | €135 | -€16,085 | -99.2% |
| Accrued charges and deferred income | 492/3 | - | €151,725 | +€151,725 | |
| Remuneration, social security and pensions | 62 | - | €192,656 | +€192,656 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €0 | €43,623 | +€43,623 | |
| Other operating charges | 640/8 | €1,561 | €1,748 | +€186 | +11.9% |
| Non-recurring operating charges | 66A | €2,060 | €0 | -€2,060 | -100% |
| Gross operating margin | 9900 | -€24,727 | €150,482 | +€175,210 | |
| Operating profit (loss) | 9901 | -€28,348 | -€87,544 | -€59,196 | -209% |
| Financial income | 75/76B | €1,127 | €13 | -€1,113 | -98.8% |
| Recurring financial income | 75 | €1,127 | €13 | -€1,113 | -98.8% |
| Financial charges | 65/66B | €3,840 | €8,483 | +€4,643 | +121% |
| Recurring financial charges | 65 | €3,840 | €8,483 | +€4,643 | +121% |
| Profit (loss) for the period before taxes | 9903 | -€31,061 | -€96,013 | -€64,952 | -209% |
| Profit (loss) for the period | 9904 | -€31,061 | -€96,013 | -€64,952 | -209% |
| Profit (loss) for the period to be appropriated | 9905 | -€31,061 | -€96,013 | -€64,952 | -209% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.